Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Nakata

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The FEBS Journal|May 30, 2009
Molecular design of a nylon-6 byproduct-degrading enzyme from a carboxylesterase with a beta-lactamase foldYasuyuki Kawashima, Taku Ohki, Naoki Shibata, et al.
Molecular Biology Reports|November 30, 2021
A preliminary genetic association study of GAD1 and GABAB receptor genes in patients with treatment-resistant schizophreniaAtsuhiro Miyazawa, Nobuhisa Kanahara, Masanobu Kogure, et al.
Neuropsychopharmacology Reports|November 12, 2025
A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case ReportMariko Tsukiji, Kaori Yamazaki, Yusuke Nakata, et al.
Auris, Nasus, Larynx|July 21, 2016
Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II studyYusuke Nakata, Kei Ijichi, Nobuhiro Hanai, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|August 27, 2025
Successful use of clozapine in a patient with schizophrenia comorbid with 22q11.2 deletion syndrome and multiple periventricular nodular heterotopia: A case reportKiwamu Hoshi, Koichi Matsuyama, Yasunori Oda, et al.
Journal of Psychopharmacology (Oxford, England)|July 3, 2023
Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practiceFumiaki Yamasaki, Nobuhisa Kanahara, Yusuke Nakata, et al.
Clinical and Experimental Dental Research|April 14, 2020
Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survivalMasaharu Noi, Ken-Ichi Mukaisho, Shoko Murakami, et al.
Schizophrenia Research. Cognition|August 8, 2020
Autistic traits and cognitive profiles of treatment-resistant schizophreniaYusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, et al.
Innovations (Philadelphia, Pa.)|February 2, 2026
Inhaled Nitric Oxide Reduces Lung Injury During Cardiac Surgery With One-Lung Ventilation in an Experimental Pig ModelHiroshi Mitsuo, Tomoki Ushijima, Hikaru Uchiyama, et al.
Journal of Psychiatric Research|April 18, 2021
Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTRYusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The FEBS Journal|May 30, 2009
Molecular design of a nylon-6 byproduct-degrading enzyme from a carboxylesterase with a beta-lactamase foldYasuyuki Kawashima, Taku Ohki, Naoki Shibata, et al.
Molecular Biology Reports|November 30, 2021
A preliminary genetic association study of GAD1 and GABAB receptor genes in patients with treatment-resistant schizophreniaAtsuhiro Miyazawa, Nobuhisa Kanahara, Masanobu Kogure, et al.
Neuropsychopharmacology Reports|November 12, 2025
A Japanese Pregnant Woman With Treatment-Resistant Schizophrenia Who Continued Clozapine With Blood Concentration Monitoring During the Perinatal Period and Had a Healthy Baby: A Case ReportMariko Tsukiji, Kaori Yamazaki, Yusuke Nakata, et al.
Auris, Nasus, Larynx|July 21, 2016
Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II studyYusuke Nakata, Kei Ijichi, Nobuhiro Hanai, et al.
PCN Reports : Psychiatry and Clinical Neurosciences|August 27, 2025
Successful use of clozapine in a patient with schizophrenia comorbid with 22q11.2 deletion syndrome and multiple periventricular nodular heterotopia: A case reportKiwamu Hoshi, Koichi Matsuyama, Yasunori Oda, et al.
Journal of Psychopharmacology (Oxford, England)|July 3, 2023
Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practiceFumiaki Yamasaki, Nobuhisa Kanahara, Yusuke Nakata, et al.
Clinical and Experimental Dental Research|April 14, 2020
Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survivalMasaharu Noi, Ken-Ichi Mukaisho, Shoko Murakami, et al.
Schizophrenia Research. Cognition|August 8, 2020
Autistic traits and cognitive profiles of treatment-resistant schizophreniaYusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, et al.
Innovations (Philadelphia, Pa.)|February 2, 2026
Inhaled Nitric Oxide Reduces Lung Injury During Cardiac Surgery With One-Lung Ventilation in an Experimental Pig ModelHiroshi Mitsuo, Tomoki Ushijima, Hikaru Uchiyama, et al.
Journal of Psychiatric Research|April 18, 2021
Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTRYusuke Nakata, Nobuhisa Kanahara, Atsushi Kimura, et al.
Pageof 5